Copyright
©The Author(s) 2015.
World J Hepatol. May 8, 2015; 7(7): 980-992
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.980
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.980
Figure 1 Principles of immunotherapy on hepatocellular carcinoma.
NK: Natural killer; LAK: Lymphokine-activated killer; NKT: Natural killer T; CIK: Chemokine-induced killer; CAR-T: Chimeric antigen receptor-T; HBV: Hepatitis B virus; MDSC: Myeloid-derived suppressor cells; Treg: Regulatory T; IL-2: Interleukin 2; IFN: Interferon; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation; HCC: Hepatocellular carcinoma.
- Citation: Hong YP, Li ZD, Prasoon P, Zhang Q. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015; 7(7): 980-992
- URL: https://www.wjgnet.com/1948-5182/full/v7/i7/980.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i7.980